Lung Neuroendocrine Tumor G1
specificA neuroendocrine tumor of the lung characterized by the absence of necrosis and the presence of less than 2 mitoses per 2 mm2.
15
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Lung Neuroendocrine Tumor G1(15)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 53.3 |
| 2 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 53.3 |
| 3 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 53.3 |
| 4 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 53.3 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 53.3 |
| 6 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 53.3 |
| 7 | NCI Clinical Active Research Program | 53.3 |
| 8 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 53.3 |
| 9 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.3 |
| 10 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.3 |
| 11 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 53.3 |
| 12 | Boston University Cancer CenterBoston, MA Active Research Program | 53.3 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.3 |
| 14 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 53.3 |
| 15 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 53.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →